HCN News Team – Page 260 – Highly Capitalized

Wednesday, May 6, 2026 We Follow The Money.

About HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Ascend Wellness Plans to Raise $7 Million in Private Placement Offering for Strategic Acquisitions

HCN News Team2023-07-27T19:07:13-08:00July 27th, 2023|Business|

NEW YORK — Ascend Wellness, a prominent cannabis multistate operator ...

California Proposal Seeks to Establish $5 Billion Psychedelics Research Agency

HCN News Team2023-07-27T19:03:29-08:00July 27th, 2023|Insights|

LOS ANGELES— A group of strategists from California has formally ...

House Approves Measures to Expand Medical Cannabis Access for Veterans and Fund Psychedelic Research

HCN News Team2023-07-27T18:59:16-08:00July 27th, 2023|Insights|

WASHINGTON, D.C. — In a significant move for veterans' healthcare ...

Tilray Surges 15% Amidst Q4 Results, But Skepticism Lingers for Investors

HCN News Team2023-07-27T16:51:43-08:00July 27th, 2023|Capital|

LOS ANGELES-Tilray Brands, the Canadian cannabis producer with hopes of ...

Mastercard Bars Cannabis Transactions on Debit Cards, Dealing a Blow to the Industry

HCN News Team2023-07-27T16:25:04-08:00July 27th, 2023|Business|

NEW YORK-In a recent move, Mastercard (MA.N) has directed financial ...

ACLU Backs Citizens’ Initiative for Recreational Cannabis in Florida, Challenges Supreme Court Review

HCN News Team2023-07-27T12:51:08-08:00July 27th, 2023|Justice|

LOS ANGELES-- The American Civil Liberties Union of Florida (ACLU) ...

Women’s Canna Awards Returns For Second Year

HCN News Team2023-07-27T20:05:56-08:00July 27th, 2023|The Hive|

SACRAMENTO– The Women’s Canna Awards, produced by Debutante Honors, Inc, ...

Falling Stock Prices Force Down Cannabis Industry CEO Pay in 2022

HCN News Team2023-07-27T09:47:43-08:00July 27th, 2023|Business|

LOS ANGELES-The cannabis industry has been a rollercoaster ride for ...

InMed Pharmaceuticals Evaluates Options for Promising INM-755 Compound After Successful Clinical Trial

HCN News Team2023-07-27T09:33:35-08:00July 27th, 2023|Brands|

LOS ANGELES-- Following the encouraging results of its Phase II ...

Ohio’s Adult-Use Cannabis Legalization Bid Requires More Signatures

HCN News Team2023-07-27T09:22:02-08:00July 27th, 2023|Insights|

LOS ANGELES-- Ohio voters could potentially see the issue of ...

Previous 259260261 Next

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.